CompletedPhase 2NCT03486678

SHR-1210 in Combination With GEMOX in Patients With Advanced BTC

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The First Affiliated Hospital with Nanjing Medical University
Principal Investigator
Yongqian Shu, PhD
JANGSU PROVINCE HOSPITAL
Intervention
SHR-1210+GEMOX(drug)
Enrollment
38 enrolled
Eligibility
18-75 years · All sexes
Timeline
20182020

Study locations (1)

Collaborators

Jiangsu HengRui Medicine Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03486678 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma

← Back to all trials